REGULATORY INTELLIGENCE·Recall
Sandoz Infuvite Pediatric Recall: Sub-Optimal Vial Crimping Exposes Critical Container Integrity Risks
Sandoz Inc. initiated a Class II recall for 17,500 units of INFUVITE PEDIATRIC (Multiple Vitamins Injection) due to sub-optimal vial crimping. This FDA-terminated recall, impacting nationwide U.S. distribution, underscores the critical importance of container closure integrity in sterile pharmaceutical products. Procurement and regulatory teams must scrutinize packaging supplier quality and manufacturing process controls to mitigate similar supply chain disruptions.
90-Day Activity